Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin in invasive candidiasis or candidemia
NCT01982071Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in invasive candidiasis, candidemia, sponsored by Astellas Pharma. Started Sep 2013; status: terminated.
02
Drugs
micafungin
03
Conditions
invasive candidiasiscandidemia
Beyond the preview
Go deeper on NCT01982071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01982071.